The New York Times, Often a Public Policy Shaper, Runs Article on 340B Pricing Denials

The headline and deck on the Dec. 15 online version of New York Times correspondent Sheryl Gay Stolberg’s article about pressure on HHS to act on drug manufacturers’ denials of 340B pricing.

The New York Times, Often a Public Policy Shaper, Runs Article on 340B Pricing Denials

The New York Times has published a news article about “top pharmaceutical companies [that] have stopped giving federally mandated drug discounts to hospitals and clinics that care for the poorest Americans,” and the bipartisan pressure building on outgoing U.S. Health and Human Services (HHS) Secretary Alex Azar “to demand reinstatement of the price breaks or punish the firms.”

The story by the newspaper’s Washington correspondent Sheryl Gay Stolberg, who focuses on health care policy, first ran online early last night and today in the print edition’s business section.

.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report